SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 48 filers reported holding SQZ BIOTECHNOLOGIES CO in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $202,003 | -70.3% | 2,517,173 | 0.0% | 0.00% | -75.0% |
Q2 2023 | $679,637 | -51.8% | 2,517,173 | 0.0% | 0.00% | -55.6% |
Q1 2023 | $1,409,617 | -24.3% | 2,517,173 | 0.0% | 0.01% | -30.8% |
Q4 2022 | $1,862,708 | -67.5% | 2,517,173 | 0.0% | 0.01% | -69.0% |
Q3 2022 | $5,739,000 | -28.3% | 2,517,173 | 0.0% | 0.04% | -22.2% |
Q2 2022 | $8,005,000 | -34.2% | 2,517,173 | -0.4% | 0.05% | -19.4% |
Q1 2022 | $12,162,000 | -46.2% | 2,528,477 | -0.0% | 0.07% | -40.7% |
Q4 2021 | $22,586,000 | -38.1% | 2,529,272 | -0.0% | 0.11% | -41.8% |
Q3 2021 | $36,478,000 | -0.2% | 2,529,633 | -0.0% | 0.19% | +56.5% |
Q2 2021 | $36,557,000 | +6.0% | 2,529,929 | +0.4% | 0.12% | +2.5% |
Q1 2021 | $34,476,000 | +45868.0% | 2,520,186 | +97279.7% | 0.12% | – |
Q4 2020 | $75,000 | – | 2,588 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
683 Capital Management, LLC | 1,330,889 | $984,857 | 0.08% |
Artal Group S.A. | 1,606,309 | $1,189 | 0.07% |
Sandy Cove Advisors, LLC | 51,707 | $38,263 | 0.03% |
MAVERICK CAPITAL LTD | 1,068,155 | $790,435 | 0.02% |
AMERICAN INTERNATIONAL GROUP, INC. | 2,517,173 | $1,862,708 | 0.01% |
Temasek Holdings (Private) Ltd | 2,758,169 | $2,041,045 | 0.01% |
RBF Capital, LLC | 127,930 | $94,000 | 0.01% |
ADVISORS MANAGEMENT GROUP INC /ADV | 14,000 | $10 | 0.00% |
Ergoteles LLC | 64,215 | $47,519 | 0.00% |
Baldrige Asset Management LLC | 5,000 | $4 | 0.00% |